En Connectem estamos orgullosos de apoyar a Vaxdyn en su estrategia de Fundraising. Esperamos nuevos éxitos en el...
Una empresa española diseña una rompedora vacuna para la pandemia que viene
read more
Pharma / Biotech
Vaxdyn closes seed financial round with Bionova Capital with Connectem’s support
Vaxdyn closes seed financial round with Bionova Capital with Connectem’s support, to develop a new vaccine against...
Looking for an exit of your portfolio companies?
Connectem supports the divesting process of your portfolio companies, by searching and selecting the most appropriate...
Premio Everis España 2020
Un año más, Karim Balan, Managing Partner de Connectem Healthcare Business Consulting, formará parte del...
Colaboración entre Vaxdyn y Reig Jofre para el desarrollo de una nueva vacuna
Queremos compartir la noticia de la colaboración entre Vaxdyn y Reig Jofre para el desarrollo de una nueva vacuna...
Don’t forget about the Superbugs
The quest for vaccines In times of SARS-CoV-2 (Coronavirus), which causes COVID-19, a disease with a complex...
EVERIS AWARDS 2018
"Entrepeneurs starting a venture are like sailors starting the adventure to cross the Atlantic by boat"
Connectem is attending Everis Awards 2018
We are proud to announce that next May 25th, Connectem will take part in the evaluation panel of the Everis Awards...
Connectem will take part in the evaluation panel of the Everis Awards 2017
We are proud to announce that Connectem will take part in the evaluation panel of the Everis Awards 2017. Karim Balan...
Nasdaq Sees Israeli Biotech IPOs Tapping the Market This Year
Bloomber Technology Sharon Wrobel May 22, 2016 — 4:33 PM CEST More Israeli biotech and technology companies plan to...
Connectem is attending V Bio Investor day
V BIO INVESTOR DAY 22 de Octubre. Lugo(CETAL) “Buscamos proyectos BIO para invertir” La Axencia Galega...
Mylan Launches First Trastuzumab Biosimilar, Hertraz, in India
Mylan Inc. 10/02/2014 — Biopharma News Mylan Inc., one of the world's leading generic and specialty pharmaceutical...
Prothena to Receive $30 Million Upfront Payment from Roche
Prothena Corporation plc a clinical stage biotechnology company focused on the discovery, development and...
Category
Pharma / Biotech
In Vitro Diagnostic
Medical devices
Health & Nutrition
LAST POSTS
follow US